United States Leuprorelin Acetate Market Report 2016

November 2016 | 100 pages | ID: UB893EC2DD1EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Leuprorelin Acetate

Revenue, means the sales value of Leuprorelin Acetate

This report studies sales (consumption) of Leuprorelin Acetate in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer, Inc. (US)
• AEterna Zentaris, Inc. (Canada)
• AstraZeneca Plc. (UK)
• Bayer HealthCare Pharmaceuticals, Inc. (USA)
• Eli Lilly and Company (USA)
• Meditrina Pharmaceuticals, Inc. (US)
• Neurocrine Biosciences, Inc. (US)
• Abbott Laboratories (USA)
• Repros Therapeutics, Inc. (US)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Leuprorelin Acetate in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Leuprorelin Acetate Market Report 2016

1 LEUPRORELIN ACETATE OVERVIEW

1.1 Product Overview and Scope of Leuprorelin Acetate
1.2 Classification of Leuprorelin Acetate
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Leuprorelin Acetate
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Leuprorelin Acetate (2011-2021)
  1.4.1 United States Leuprorelin Acetate Sales and Growth Rate (2011-2021)
  1.4.2 United States Leuprorelin Acetate Revenue and Growth Rate (2011-2021)

2 UNITED STATES LEUPRORELIN ACETATE COMPETITION BY MANUFACTURERS

2.1 United States Leuprorelin Acetate Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Leuprorelin Acetate Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Leuprorelin Acetate Average Price by Manufactures (2015 and 2016)
2.4 Leuprorelin Acetate Market Competitive Situation and Trends
  2.4.1 Leuprorelin Acetate Market Concentration Rate
  2.4.2 Leuprorelin Acetate Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES LEUPRORELIN ACETATE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Leuprorelin Acetate Sales and Market Share by Type (2011-2016)
3.2 United States Leuprorelin Acetate Revenue and Market Share by Type (2011-2016)
3.3 United States Leuprorelin Acetate Price by Type (2011-2016)
3.4 United States Leuprorelin Acetate Sales Growth Rate by Type (2011-2016)

4 UNITED STATES LEUPRORELIN ACETATE SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Leuprorelin Acetate Sales and Market Share by Application (2011-2016)
4.2 United States Leuprorelin Acetate Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES LEUPRORELIN ACETATE MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer, Inc. (US)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Leuprorelin Acetate Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer, Inc. (US) Leuprorelin Acetate Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 AEterna Zentaris, Inc. (Canada)
  5.2.2 Leuprorelin Acetate Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 AEterna Zentaris, Inc. (Canada) Leuprorelin Acetate Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 AstraZeneca Plc. (UK)
  5.3.2 Leuprorelin Acetate Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 AstraZeneca Plc. (UK) Leuprorelin Acetate Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Bayer HealthCare Pharmaceuticals, Inc. (USA)
  5.4.2 Leuprorelin Acetate Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Bayer HealthCare Pharmaceuticals, Inc. (USA) Leuprorelin Acetate Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Eli Lilly and Company (USA)
  5.5.2 Leuprorelin Acetate Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Eli Lilly and Company (USA) Leuprorelin Acetate Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Meditrina Pharmaceuticals, Inc. (US)
  5.6.2 Leuprorelin Acetate Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Meditrina Pharmaceuticals, Inc. (US) Leuprorelin Acetate Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Neurocrine Biosciences, Inc. (US)
  5.7.2 Leuprorelin Acetate Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Neurocrine Biosciences, Inc. (US) Leuprorelin Acetate Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Abbott Laboratories (USA)
  5.8.2 Leuprorelin Acetate Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Abbott Laboratories (USA) Leuprorelin Acetate Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Repros Therapeutics, Inc. (US)
  5.9.2 Leuprorelin Acetate Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Repros Therapeutics, Inc. (US) Leuprorelin Acetate Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview

6 LEUPRORELIN ACETATE MANUFACTURING COST ANALYSIS

6.1 Leuprorelin Acetate Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Leuprorelin Acetate

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Leuprorelin Acetate Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Leuprorelin Acetate Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES LEUPRORELIN ACETATE MARKET FORECAST (2016-2021)

10.1 United States Leuprorelin Acetate Sales, Revenue Forecast (2016-2021)
10.2 United States Leuprorelin Acetate Sales Forecast by Type (2016-2021)
10.3 United States Leuprorelin Acetate Sales Forecast by Application (2016-2021)
10.4 Leuprorelin Acetate Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Leuprorelin Acetate
Table Classification of Leuprorelin Acetate
Figure United States Sales Market Share of Leuprorelin Acetate by Type in 2015
Table Application of Leuprorelin Acetate
Figure United States Sales Market Share of Leuprorelin Acetate by Application in 2015
Figure United States Leuprorelin Acetate Sales and Growth Rate (2011-2021)
Figure United States Leuprorelin Acetate Revenue and Growth Rate (2011-2021)
Table United States Leuprorelin Acetate Sales of Key Manufacturers (2015 and 2016)
Table United States Leuprorelin Acetate Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Leuprorelin Acetate Sales Share by Manufacturers
Figure 2016 Leuprorelin Acetate Sales Share by Manufacturers
Table United States Leuprorelin Acetate Revenue by Manufacturers (2015 and 2016)
Table United States Leuprorelin Acetate Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Leuprorelin Acetate Revenue Share by Manufacturers
Table 2016 United States Leuprorelin Acetate Revenue Share by Manufacturers
Table United States Market Leuprorelin Acetate Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Leuprorelin Acetate Average Price of Key Manufacturers in 2015
Figure Leuprorelin Acetate Market Share of Top 3 Manufacturers
Figure Leuprorelin Acetate Market Share of Top 5 Manufacturers
Table United States Leuprorelin Acetate Sales by Type (2011-2016)
Table United States Leuprorelin Acetate Sales Share by Type (2011-2016)
Figure United States Leuprorelin Acetate Sales Market Share by Type in 2015
Table United States Leuprorelin Acetate Revenue and Market Share by Type (2011-2016)
Table United States Leuprorelin Acetate Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Leuprorelin Acetate by Type (2011-2016)
Table United States Leuprorelin Acetate Price by Type (2011-2016)
Figure United States Leuprorelin Acetate Sales Growth Rate by Type (2011-2016)
Table United States Leuprorelin Acetate Sales by Application (2011-2016)
Table United States Leuprorelin Acetate Sales Market Share by Application (2011-2016)
Figure United States Leuprorelin Acetate Sales Market Share by Application in 2015
Table United States Leuprorelin Acetate Sales Growth Rate by Application (2011-2016)
Figure United States Leuprorelin Acetate Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Leuprorelin Acetate Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Leuprorelin Acetate Sales Market Share (2011-2016)
Table AEterna Zentaris, Inc. (Canada) Basic Information List
Table AEterna Zentaris, Inc. (Canada) Leuprorelin Acetate Sales, Revenue, Price and Gross Margin (2011-2016)
Table AEterna Zentaris, Inc. (Canada) Leuprorelin Acetate Sales Market Share (2011-2016)
Table AstraZeneca Plc. (UK) Basic Information List
Table AstraZeneca Plc. (UK) Leuprorelin Acetate Sales, Revenue, Price and Gross Margin (2011-2016)
Table AstraZeneca Plc. (UK) Leuprorelin Acetate Sales Market Share (2011-2016)
Table Bayer HealthCare Pharmaceuticals, Inc. (USA) Basic Information List
Table Bayer HealthCare Pharmaceuticals, Inc. (USA) Leuprorelin Acetate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer HealthCare Pharmaceuticals, Inc. (USA) Leuprorelin Acetate Sales Market Share (2011-2016)
Table Eli Lilly and Company (USA) Basic Information List
Table Eli Lilly and Company (USA) Leuprorelin Acetate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly and Company (USA) Leuprorelin Acetate Sales Market Share (2011-2016)
Table Meditrina Pharmaceuticals, Inc. (US) Basic Information List
Table Meditrina Pharmaceuticals, Inc. (US) Leuprorelin Acetate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Meditrina Pharmaceuticals, Inc. (US) Leuprorelin Acetate Sales Market Share (2011-2016)
Table Neurocrine Biosciences, Inc. (US) Basic Information List
Table Neurocrine Biosciences, Inc. (US) Leuprorelin Acetate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Neurocrine Biosciences, Inc. (US) Leuprorelin Acetate Sales Market Share (2011-2016)
Table Abbott Laboratories (USA) Basic Information List
Table Abbott Laboratories (USA) Leuprorelin Acetate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Laboratories (USA) Leuprorelin Acetate Sales Market Share (2011-2016)
Table Repros Therapeutics, Inc. (US) Basic Information List
Table Repros Therapeutics, Inc. (US) Leuprorelin Acetate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Repros Therapeutics, Inc. (US) Leuprorelin Acetate Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Leuprorelin Acetate
Figure Manufacturing Process Analysis of Leuprorelin Acetate
Figure Leuprorelin Acetate Industrial Chain Analysis
Table Raw Materials Sources of Leuprorelin Acetate Major Manufacturers in 2015
Table Major Buyers of Leuprorelin Acetate
Table Distributors/Traders List
Figure United States Leuprorelin Acetate Production and Growth Rate Forecast (2016-2021)
Figure United States Leuprorelin Acetate Revenue and Growth Rate Forecast (2016-2021)
Table United States Leuprorelin Acetate Production Forecast by Type (2016-2021)
Table United States Leuprorelin Acetate Consumption Forecast by Application (2016-2021)